{"product_id":"cancer-gene-therapy-by-viral-and-nonviral-vectors-9781118501627","title":"Cancer Gene Therapy by Viral and Nonviral Vectors","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003eProvides expert, state-of-the-art insight into the current progress of viral and non-viral gene therapy\u003c\/b\u003e\u003cbr\u003e \u003cbr\u003e Translational medicine has opened the gateway to the era of personalized or precision medicine. No longer a one-size-fits-all approach, the treatment of cancer is now based on an understanding of underlying biologic mechanisms and is increasingly being tailored to the molecular specificity of a tumor.\u003cbr\u003e This book provides a comprehensive overview of the pertinent molecular discoveries in the cancer field and explains how these are being used for gene-based cancer therapies. Designed as a volume in the Translational Oncology book series, \u003ci\u003eCancer Gene Therapy by Viral and Non-viral Vectors\u003c\/i\u003e deals with the practice of gene-therapy, with reference to vectors for gene expression and gene transfer, as well as viral therapy. It covers the history and current and future applications of gene transfer in cancer, and provides expert insight on the progress of vir\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003e\u003ci\u003eList of Contributors, vii\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eSeries Foreword, ix\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003ePreface, xi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart I Delivery Systems\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Translational Cancer Research: Gene Therapy by Viral and Non-viral Vectors, 3\u003cbr\u003e \u003ci\u003eVincenzo Cerullo, Kilian Guse, Markus Vähä-Koskela, and Akseli Hemminki\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Retroviruses for Cancer Therapy, 21\u003cbr\u003e \u003ci\u003eJiehua Zhou, Yue Ding, John C. Burnett, and John Rossi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 DNA Plasmids for Non-viral Gene Therapy of Cancer, 39\u003cbr\u003e \u003ci\u003eAmer M. Najjar, Judy S.E. Moyes, and Laurence J.N. Cooper\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Cancer Therapy with RNAi Delivered by Non-viral Membrane\/Core Nanoparticles, 61\u003cbr\u003e \u003ci\u003eAndrew B. Satterlee and Leaf Huang\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II Targeted Expression\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e5 Cancer Gene Therapy by Tissue-specific and Cancer-targeting Promoters, 81\u003cbr\u003e \u003ci\u003eJennifer L. Hsu, Longfei Huo, Chia-Wei Li, Yi-Hsin Hsu, Yan Wang, and Mien-Chie Hung\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 MicroRNAs as Drugs and Drug Targets in Cancer, 97\u003cbr\u003e \u003ci\u003eHui Ling and George A. Calin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III Principles of Clinical Trials in Gene Therapy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e7 Regulatory Issues for Manufacturers of Viral Vectors and Vector-transduced Cells for Phase I\/II Trials, 115\u003cbr\u003e \u003ci\u003eAdrian P. Gee and Zhuyong Mei\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 US Regulations Governing Clinical Trials in Gene Therapy, 131\u003cbr\u003e \u003ci\u003eBambi Grilley\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Remaining Obstacles to the Success of Cancer Gene Therapy, 151\u003cbr\u003e \u003ci\u003eMalcolm K. Brenner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eIndex, 157\u003c\/i\u003e\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49406881038679,"sku":"9781118501627","price":128.2,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781118501627.jpg?v=1730497432","url":"https:\/\/bookcurl.com\/products\/cancer-gene-therapy-by-viral-and-nonviral-vectors-9781118501627","provider":"Book Curl","version":"1.0","type":"link"}